Back to Search
Start Over
Neurotoxic events associated with BCR-ABL1 tyrosine kinase inhibitors: a case series
- Source :
- Leukemia & Lymphoma. 60:3292-3295
- Publication Year :
- 2019
- Publisher :
- Informa UK Limited, 2019.
-
Abstract
- BCR-ABL1 tyrosine kinase inhibitors (TKIs) alone and with chemotherapy led to a dramatic increase in survival of chronic myeloid leukemia (CML) and Philadelphia-positive acute lymphoblastic leukemi...
- Subjects :
- Cancer Research
Chemotherapy
business.industry
medicine.medical_treatment
Myeloid leukemia
Myelitis
Hematology
medicine.disease
Fusion protein
respiratory tract diseases
03 medical and health sciences
Myelogenous
Leukemia
Bcr abl1
0302 clinical medicine
Oncology
hemic and lymphatic diseases
030220 oncology & carcinogenesis
Cancer research
Medicine
business
Tyrosine kinase
030215 immunology
Subjects
Details
- ISSN :
- 10292403 and 10428194
- Volume :
- 60
- Database :
- OpenAIRE
- Journal :
- Leukemia & Lymphoma
- Accession number :
- edsair.doi...........3b0373ea53e0e58c5320edb6ed697ecf
- Full Text :
- https://doi.org/10.1080/10428194.2019.1633635